DTIL Stock Analysis: Buy, Sell, or Hold?
DTIL - Precision BioSciences, Inc. Common Stock
$5.82
0.13 (2.28%)
▲
5d:
-11.01%
30d:
+22.01%
90d:
+39.9%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Smart Money Accumulation
DTIL is down 8.0% this week, but smart money is accumulating calls. Top strike: $5 2026-05-15 with 205 OI. Call ratio: 100% View Scanner →
Strength: 9.0/10
Get Alerted When DTIL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DTIL is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: DTIL is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: DTIL is currently trading at $5.82, which is considered fair relative to its 30-day fair value range of $4.44 to $6.40.
Technical Outlook: Technically, DTIL is showing sideways momentum. Immediate support is located at $5.35, while resistance sits at $6.86.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.00 (+449.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DTIL is showing sideways momentum. Immediate support is located at $5.35, while resistance sits at $6.86.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.00 (+449.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$4.44 -
$6.40
Company Quality Score
53/100
(HOLD)
Options IV Signal
18th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 18th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 449.8% below Wall St target ($32.00)
- WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.44 -
$6.40
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.02
(17.4%)
Support & Resistance Levels
Support Level
$5.35
Resistance Level
$6.86
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.71
Wall Street Target
$32.00
(+449.8%)
Revenue Growth (YoY)
5261.1%
Profit Margin
-133.4%
Share & Embed Analysis
Last updated: April 02, 2026 8:05 PM ET
Data refreshes hourly during market hours. Next update: 9:05 PM
Data refreshes hourly during market hours. Next update: 9:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DTIL showing a specific setup today?
Insider Activity (6 Months)
3
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
John Alexander Kelly
SELL
8149 shares
2026-02-18
Michael Amoroso
SELL
20559 shares
2026-02-18
J. Jefferson Smith
SELL
4925 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 53 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 53 HOLD |
